T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

Cellev8 Continues to breakthrough, enhance and improve the lives of athletes globally WELLINGTON, FL / ACCESS Newswire / February 11, 2025 / Innovative Wellness Company Teams Up with Hall of Famer to ...

Transitioning from general sales to pharmaceutical sales can be an exciting career move that often offers better earning ...

Product Launch Leverages IGC's State-Of-The-Art Manufacturing Facility To Support Revenue-Generating Brand for Immunity & Energy - POTOMAC, MD / ACCESS Newswire / February 11, 2025 / IGC Pharma, Inc.

Aston Institute for Membrane Excellence (AIME) has been awarded £6.1m in funding from the UK Government Department of Science, Industry and Technology (DSIT), with a further £7.1m in co-funding from ...

Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today it is ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral respiratory infections, announces today it has received a ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum ...

FORT LAUDERDALE, FL / ACCESS Newswire / February 11, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and ...

Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH11.02.2025 / 13:35 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The ...

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer ...